GlassScriptPhysician profile
Andrew C Gordon
NPI 1578911061
$8,857.29
in general payments reported to CMS, 2019-2025
9 companies · $5,854 in 2025
The $5,854 reported for 2025 was more than what 86% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,235 · 2021: $146 · 2022: $91.69 · 2023: $161 · 2024: $369 · 2025: $5,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $884.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,500.00 | 2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $2,100.00 | 2020 | |
| Boston Scientific Corporation | $642.65 | 2020-2025 | General - Interventional Oncology, Obsidio, Therasphere Administration Set |
| Penumbra, INC. | $284.78 | 2021-2024 | Indigo System |
| Abk Biomedical USA, INC. | $222.07 | 2025 | Eye90 Microspheres |
| W. L. Gore & Associates, INC. | $39.27 | 2024-2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion, Gore Viabil Biliary Endoprosthesis |
| Terumo Medical Corporation | $37.47 | 2022-2024 | Angio-Seal, Hydropearl, Navicross |
| Argon Medical Devices, INC. | $18.96 | 2025 | Clot Management |
| Medtronic, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.